Inventor · disambiguated record
Friedemann Krause
Also filed as: KRAUSE FRIEDEMANN
6 granted patents·10 pending applications·156 citations·filing 1993–2021
82Inventor score
Files withHOFFMANN LA ROCHE4ROCHE DIAGNOSTICS OPERATIONS INC4BOEHRINGER MANNHEIM GMBH3ROCHE DIAGNOSTICS OPERATIONS2ROCHE DIAGNOSTICS GMBH1
Top patents by PatentIndex Score
16 records- 0186US5463228AApparatus for the detection of a fluid phase boundary in a transparent measuring tube and for the automatic exact metering of an amount of liquidBOEHRINGER MANNHEIM GMBH·Filed 1993·Granted Oct 31, 1995·90 cites·14 claims
- 0267US2022034910A1Biomarkers in the selection of therapy of heart failureROCHE DIAGNOSTICS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 0366US5856200AMethod and device for metering liquidsBOEHRINGER MANNHEIM GMBH·Filed 1996·Granted Jan 5, 1999·31 cites·31 claims
- 0460US6815217B2Use of check surfaces for identifying disturbing samples in a detection procedureROCHE DIAGNOSTICS GMBH·Filed 1998·Granted Nov 9, 2004·22 cites·34 claims
- 0556US2015192587A1Use of protein s100a12 as a marker for colorectal cancerROCHE DIAGNOSTICS OPERATIONS·Filed 2014·Application pending·0 cites
- 0656US2005100936A1Methods and compositions related to prediction of drug responseROCHE MOLECULAR SYSTEMS INC·Filed 2004·Application pending·0 cites
- 0754US2014302019A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0851US2013183301A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0951US2013195857A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1051US2013108626A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 1150US12461115B2Computerized method and laboratory equipment for fast detection of failure in laboratory equipmentROCHE DIAGNOSTICS OPERATIONS INC·Filed 2021·Granted Nov 4, 2025·0 cites·16 claims
- 1246US5455177AMethod for analysis of a medical sampleBOEHRINGER MANNHEIM GMBH·Filed 1993·Granted Oct 3, 1995·13 cites·11 claims
- 1342US2010159479A1Timp-1 as a marker for colorectal cancerROLLINGER WOLFGANG·Filed 2009·Application pending·0 cites
- 1439US11402381B2Methods of identifying an individual to be treated by chemotherapy based on cytokeratin-19 fragments (CYFRA 21-1) and carcinoembryonic antigen (CEA) marker molecules and related usesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Granted Aug 2, 2022·0 cites·8 claims
- 1539US2015268251A1Biomarkers in the selection of therapy of heart failureROCHE DIAGNOSTICS OPERATIONS·Filed 2015·Application pending·0 cites
- 1633US2018292410A1Methods of detecting a relapse of a lung adenocarcinoma based on marker human epididymis protein 4 (he4) and related usesROCHE DIAGNOSTICS OPERATIONS INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Friedemann Krause files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →